Literature DB >> 6102439

Low-dose propranolol in tardive dyskinesia.

N M Bacher, H A Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102439     DOI: 10.1176/ajp.137.4.495

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors:  Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

2.  Serum neuroleptic concentrations and tardive dyskinesia.

Authors:  D V Jeste; M Linnoila; R L Wagner; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Use of beta-blocking drugs in psychiatry and neurology.

Authors:  P J Tyrer
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

4.  Use of propranolol in treating tardive dyskinesia.

Authors:  T R Einarson
Journal:  Can Med Assoc J       Date:  1981-05-15       Impact factor: 8.262

5.  Tardive Dyskinesia: Spotlight on Current Approaches to Treatment.

Authors:  Sarah M Debrey; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

6.  Brief report: effects of propranolol in Tourette syndrome.

Authors:  J Sverd; S Cohen; J A Camp
Journal:  J Autism Dev Disord       Date:  1983-06

7.  Intravenous benztropine and propranolol challenges in tardive akathisia.

Authors:  P Sachdev; C Loneragan
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.